The UK government has sealed two more deals to secure Covid-19 vaccines, buying shots in development from US drugmakers Johnson & Johnson and Novavax Inc, the chair of the UK Vaccine Taskforce.
Kate Bingham of the Covid-19 task force says 'amazing progress' has been made but it is still too early to tell whether any of the 6 vaccines the UK now has access to will work.
In a separate statement, Novavax said the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial.
The UK has now placed orders for six experimental vaccines, with a total potential stockpile of 340 million doses.
That is enough for everyone in the UK to receive five doses.
Get the latest headlines: [ Ссылка ]
Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.
